Literature DB >> 26914603

Therapeutics in clinical toxicology: in the absence of strong evidence how do we choose between antidotes, supportive care and masterful inactivity.

Geoffrey K Isbister1,2, Nicholas A Buckley2,3.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26914603      PMCID： PMC4767208          DOI： 10.1111/bcp.12819

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  24 in total

1.  In reply.

Authors:  Geoffrey K Isbister; Colin B Page; Geoffrey K Isbister; Nicholas A Buckley; Daniel M Fatovich; Simon G A Brown
Journal:  Ann Emerg Med       Date:  2015-01       Impact factor: 5.721

2.  How do we assess whether the QT interval is abnormal: myths, formulae and fixed opinion.

Authors:  Geoffrey K Isbister
Journal:  Clin Toxicol (Phila)       Date:  2015-02-19       Impact factor: 4.467

Review 3.  Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice.

Authors:  Geoffrey K Isbister; Colin B Page
Journal:  Br J Clin Pharmacol       Date:  2013-07       Impact factor: 4.335

4.  How do we use drug concentration data to improve the treatment of overdose patients?

Authors:  Geoffrey K Isbister
Journal:  Ther Drug Monit       Date:  2010-06       Impact factor: 3.681

5.  High doses of methylprednisolone in the management of caustic esophageal burns.

Authors:  Merve Usta; Tülay Erkan; Fugen Cullu Cokugras; Nafiye Urganci; Zerrin Onal; Mahir Gulcan; Tufan Kutlu
Journal:  Pediatrics       Date:  2014-06       Impact factor: 7.124

6.  A randomized, double-blind, placebo-controlled trial of a highly purified equine F(ab)2 antibody black widow spider antivenom.

Authors:  Richard C Dart; Gregory Bogdan; Kennon Heard; Becki Bucher Bartelson; Walter Garcia-Ubbelohde; Sean Bush; Tom Arnold; Richard C Clark; Gregory W Hendey; Christopher Holstege; Elizabeth A Spradley
Journal:  Ann Emerg Med       Date:  2013-02-04       Impact factor: 5.721

7.  Randomized controlled trial of intravenous antivenom versus placebo for latrodectism: the second Redback Antivenom Evaluation (RAVE-II) study.

Authors:  Geoffrey K Isbister; Colin B Page; Nicholas A Buckley; Daniel M Fatovich; Ovidiu Pascu; Stephen P J MacDonald; Leonie A Calver; Simon G A Brown
Journal:  Ann Emerg Med       Date:  2014-07-03       Impact factor: 5.721

Review 8.  Does gastric lavage really push poisons beyond the pylorus? A systematic review of the evidence.

Authors:  Michael Eddleston; Edmund Juszczak; Nick Buckley
Journal:  Ann Emerg Med       Date:  2003-09       Impact factor: 5.721

9.  A randomised controlled trial of intramuscular vs. intravenous antivenom for latrodectism--the RAVE study.

Authors:  G K Isbister; S G A Brown; M Miller; A Tankel; E Macdonald; B Stokes; R Ellis; Y Nagree; G J Wilkes; R James; A Short; A Holdgate
Journal:  QJM       Date:  2008-04-08

10.  Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial.

Authors:  D Nicholas Bateman; James W Dear; H K Ruben Thanacoody; Simon H L Thomas; Michael Eddleston; Euan A Sandilands; Judy Coyle; Jamie G Cooper; Aryelly Rodriguez; Isabella Butcher; Steff C Lewis; A D Bastiaan Vliegenthart; Aravindan Veiraiah; David J Webb; Alasdair Gray
Journal:  Lancet       Date:  2013-11-28       Impact factor: 79.321
View more
  3 in total

1.  Comment on "Probable Tapentadol-Associated Serotonin Syndrome After Overdose".

Authors:  Marc Russo; Danielle Santarelli; Geoff Isbister
Journal:  Hosp Pharm       Date:  2017-04

2.  First aid interventions by laypeople for acute oral poisoning.

Authors:  Bert Avau; Vere Borra; Anne-Catherine Vanhove; Philippe Vandekerckhove; Peter De Paepe; Emmy De Buck
Journal:  Cochrane Database Syst Rev       Date:  2018-12-19

Review 3.  An Appraisal of Antidotes' Effectiveness: Evidence of the Use of Phyto-Antidotes and Biotechnological Advancements.

Authors:  Christiana Eleojo Aruwa; Yusuf Ola Mukaila; Abdulwakeel Ayokun-Nun Ajao; Saheed Sabiu
Journal:  Molecules       Date:  2020-03-26       Impact factor: 4.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.